Floatz logo

Sitagliptin

Diabetes Mellitus Type 1

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Small moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Diabetes Mellitus Type 1 cohort.

Asset / SponsorPhaseRating
Metformin
Heba M. Ismail
Phase 4A
Liraglutide
Dasman Diabetes Institute
Phase 4BBB
Tirzepatide
Royal North Shore Hospital
Phase 4BBB
Semaglutide
Nordsjaellands Hospital
Phase 3BB
ct-868
Carmot Therapeutics, Inc.
Phase 2BB

View all 23 →

Same molecule, other indications

Sitagliptin is also rated in:

diabetes mellitusDormant
BBB
Indicative ·
73 / 100
View asset →
polycystic ovary syndromeDormant
BB
Indicative ·
70 / 100
View asset →
prediabetes syndromeDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →